Navigation Links
OCuSOFT(R) Lid Scrub(TM) PLUS Proven to Kill Demodex Mites
Date:12/3/2008

RICHMOND, Texas, Dec. 3 /PRNewswire/ -- CYNACON/OCuSOFT(R) a broad based supplier of ophthalmic pharmaceuticals and supplies is pleased to announce the latest findings from a recent study(1). OCuSOFT(R) Lid Scrub(TM) PLUS, in its unique "Leave-On" formulation, was shown to effectively eradicate Demodex mites. Significantly, NO other eyelid cleanser used according to manufacturer's instructions kills Demodex.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081203/LAW014)

Recent reports suggest that the Demodex mite is a contributing factor to meibomian gland dysfunction, meibomitis, blepharitis, and other eyelid irritations. A variety of corneal pathologic features, together with conjunctival inflammation commonly noted in rosacea, can be found in patients with Demodex infestation of the eyelids.(2) Studies confirm ocular infestation of Demodex may be as high as 47%.(3)

Troy Smith, Vice President, Professional and Technical Relations, remarks, "Researchers have for some time considered Demodex mite infestation as a factor in meibomian gland disease. It is exciting to note that our new OCuSOFT(R) Lid Scrub(TM) PLUS effectively kills Demodex mites utilizing its unique 'Leave-On' formula. Significantly, in blepharitis patients, one out of every six eyelashes contain Demodex mites, a number that increases with age. OCuSOFT(R) Lid Scrub(TM) PLUS is the only 'Leave-On' formulation eyelid cleanser on the market facilitating optimal Demodex kill rates."

Nat G. Adkins, Jr., OCuSOFT's Chairman, adds, "Practitioners are now recognizing that eradication of Demodex can significantly improve patient comfort and quality of life. OCuSOFT(R) is pleased to once again be at the forefront of lid disease and ocular surface therapy."

For more information or to acquire samples please call 800-233-5469 or visit http://www.ocusoft.com. Additionally, as a convenience to patients, OCuSOFT(R) Lid Scrub(TM) PLUS is available at CVS, Duane Reade and Long's Drug Stores.

(1) Yee, M.D., Richard. Efficacy of OCuSOFT(R) Lid Scrub(TM) PLUS on Eradication of Ocular Demodex. 2008, July. Study on file.

(2) A . Kheirkhah, et. al. Corneal Manifestations of Ocular Demodex Infestation. American Journal of Ophthalmology, 2007 May; 143(5):743 - 49.

(3) Norn, MS. Incidence of Demodex folliculorum on skin of lids and nose. Acta Opthalmologica. 1982 Aug; 60(4):575-83.


'/>"/>
SOURCE OCuSOFT
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CYNACON / OCuSOFT(R) Announces OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies
2. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
3. Proven Nutrition Provides Energy and Hope to Cancer Fighters
4. Benefit of exenatide has not yet been proven
5. Smoked cannabis proven effective in treating neuropathic pain
6. Infliximab scheduled treatment has proven to be an effective strategy in IBD patients
7. Gildas Club Worldwide is a Proven Partner in Quality Cancer Care
8. New Booklet Reveals 12 Proven Methods for Stopping MRSA from Infecting Your Feet and Your Familys Feet
9. Many Osteoporosis Medications Prevent Fractures, But None Is Proven Best
10. Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend
11. Companys Award-Winning Sound Enhancement Technology Proven to Provide Superior Performance Over Other Technologies; Patent Will Enhance Able Planet, LINX AUDIO Brands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of ... of Pittsburgh points to eight genes that may explain why susceptibility to one of ... results of a study published today in the journal npj Schizophrenia. , “There ...
(Date:2/24/2017)... ... February 24, 2017 , ... Healthcare Associates of ... Center at Craig Ranch building at 8080 State Highway 121, Suite 210, McKinney, Texas ... easy access to Highway 121. , As the practice has grown, the need for ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals ... What You See” body image mannequin art competition. Selected from 15 submissions from around ... winner revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... again hosted their Military Wedding Giveaway, with the winning couple announced on Feb. ... with services generously donated from local vendors: A Matter of Taste, Ryan Rousseau ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... and Strategies - 2016" report to their offering. ... The latest research Autism ... pricing data and benchmarks in the global Autism Spectrum Disorder market. ... What are the key drugs marketed for Autism Spectrum Disorder ...
(Date:2/23/2017)... Limited, ( ASX: ITD ), an innovative diversified healthcare company, is ... December 2016 compared with the previous corresponding period. A full "Results ... . Highlights Profit after ... Earnings per share of 2.2 cents (Dec 2015: 1.2 cents; up ... 11%) Profit before tax of $2.12m (Dec 2015: ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
Breaking Medicine Technology: